Photo by Tingey Injury Law Firm on Unsplash
Billion-Dollar Duel Between Berkshire and Haslams Canceled
January 8, 2024
The much-anticipated billion-dollar court trial determining whether Berkshire Hathaway used improper accounting techniques in its purchase of the Haslam family’s minority stake in Pilot Travel Centers was surprisingly canceled in Delaware Chancery Court. Instead of a trial, the two sides have agreed to a settlement, though the terms were not disclosed to the public.
Pilot Travel Centers, the largest truck-stop chain in the U.S., is predominantly under the control of Berkshire Hathaway, led by CEO Warren Buffett. This control was brought about by several purchases, totaling $11 billion, that gave Berkshire an 80% stake in Pilot Travel Centers. The remaining minority stake is owned by the Haslam family, which had a “put option” to force Berkshire to buy out their remaining 20% within a specific annual time frame.
The Haslams had filed a suit against Berkshire Hathaway last year, accusing it of using a form of accounting dubbed “pushdown accounting,” which would devalue Pilot Travel Centers. This, according to the Haslams, would see them get short-changed in the event that Berkshire Hathaway bought out their remaining stake. On the other hand, Berkshire maintained that its use of the accounting method was fully within the framework of its agreement with the Haslams.
Adding to the contentious situation, there were claims that Jimmy Haslam, a family member who owns the Cleveland Browns football team, might have offered illicit side payments to Pilot Travel Centers’ top executives. These allegations, which were being investigated by federal prosecutors in New York, were meant to inflate the value of the Haslam family’s remaining stake in the company, forcing Berkshire to pay more than it should have.
The cancelation of the trial came just two days after a brief conference where the judge in charge of the case met with the attorneys for Berkshire and the Haslams to finalize the trial details. Greg Abel, Buffett’s designated successor, was expected to testify.
The outcome of the trial could have seen Berkshire Hathaway paying up to $1.2 billion more for the Haslam’s stake in the company than it would have if the alleged accounting methods were not used. Both Berkshire Hathaway and the Haslam family have been tight-lipped about the canceled trial and settlement.
Recent News
Massive Data Breach Hits Ticketmaster, Affecting 560 Million Customers
Ticketmaster has fallen victim to a significant cyber-attack, potentially compromising the data of up to 560 million customers. The breach was confirmed by Ticketmaster’s parent company, Live Nation, which revealed that a notorious hacking group, ShinyHunters, is behind the attack. The hackers are demanding a ransom of approximately £400,000 to prevent the data from being sold on the dark web.
Toyota Recalls 100,000+ Tundra and Lexus LX SUVs Over Engine Debris Issue
Toyota has announced a recall for over 100,000 Tundra pickups and Lexus LX SUVs in North America due to potential engine issues caused by machining debris. This recall affects certain 2022-2023 models of the Tundra and LX, which are equipped with the new V6 twin-turbo engine. The V6 twin-turbo engine has faced considerable scrutiny regarding its reliability, especially when compared to the previous naturally aspirated V8 engines.
Wordle and Worldle Battle Over Names
A legal dispute has erupted between the wildly popular word game Wordle and the lesser-known geography game Worldle, centering on the similarity of their names. Wordle, which was developed by Josh Wardle in 2021 and later acquired by the New York Times in 2022 for a substantial sum, has gained immense popularity. In this game, players have six attempts to guess a five-letter word.
FDA Issues Recall for Crecelac Goat Milk Infant Formula
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding Crecelac Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. The alert highlights Cronobacter contamination concerns with Crecelac Infant Powdered Goat Milk Infant Formula. Although Dairy Manufacturers Inc. initiated a recall on May 24, 2024, due to non-compliance with FDA regulations, new findings of Cronobacter contamination have prompted further action.